[go: up one dir, main page]

FR2862646B1 - Nouveaux composes antidiabetiques contenant des derives benzofuranes, benzothiophenes - Google Patents

Nouveaux composes antidiabetiques contenant des derives benzofuranes, benzothiophenes

Info

Publication number
FR2862646B1
FR2862646B1 FR0313615A FR0313615A FR2862646B1 FR 2862646 B1 FR2862646 B1 FR 2862646B1 FR 0313615 A FR0313615 A FR 0313615A FR 0313615 A FR0313615 A FR 0313615A FR 2862646 B1 FR2862646 B1 FR 2862646B1
Authority
FR
France
Prior art keywords
benzothiophenic
derivatives
compounds containing
antidiabetic compounds
novel antidiabetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0313615A
Other languages
English (en)
Other versions
FR2862646A1 (fr
Inventor
Gerard Moinet
Caroline Leriche
Micheline Kergoat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
Merck Sante SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0313615A priority Critical patent/FR2862646B1/fr
Application filed by Merck Sante SAS filed Critical Merck Sante SAS
Priority to KR1020067009680A priority patent/KR20060101492A/ko
Priority to US10/579,996 priority patent/US7371774B2/en
Priority to AU2004295036A priority patent/AU2004295036B9/en
Priority to ES04797711T priority patent/ES2308270T3/es
Priority to BRPI0416790-2A priority patent/BRPI0416790A/pt
Priority to DE602004014966T priority patent/DE602004014966D1/de
Priority to EP04797711A priority patent/EP1685122B1/fr
Priority to JP2006540238A priority patent/JP4819692B2/ja
Priority to CA2546651A priority patent/CA2546651C/fr
Priority to AT04797711T priority patent/ATE400566T1/de
Priority to CNA2004800341918A priority patent/CN1882562A/zh
Priority to PCT/EP2004/012620 priority patent/WO2005054226A1/fr
Priority to MXPA06005591A priority patent/MXPA06005591A/es
Priority to ARP040104274A priority patent/AR046645A1/es
Publication of FR2862646A1 publication Critical patent/FR2862646A1/fr
Application granted granted Critical
Publication of FR2862646B1 publication Critical patent/FR2862646B1/fr
Priority to ZA200605022A priority patent/ZA200605022B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
FR0313615A 2003-11-20 2003-11-20 Nouveaux composes antidiabetiques contenant des derives benzofuranes, benzothiophenes Expired - Fee Related FR2862646B1 (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FR0313615A FR2862646B1 (fr) 2003-11-20 2003-11-20 Nouveaux composes antidiabetiques contenant des derives benzofuranes, benzothiophenes
AT04797711T ATE400566T1 (de) 2003-11-20 2004-11-08 Benzofurane und benzothiophene
AU2004295036A AU2004295036B9 (en) 2003-11-20 2004-11-08 Benzofurans and benzothiophenes
ES04797711T ES2308270T3 (es) 2003-11-20 2004-11-08 Benzofuranos y benzotiofenos.
BRPI0416790-2A BRPI0416790A (pt) 2003-11-20 2004-11-08 benzofuranos e benzotiofenos
DE602004014966T DE602004014966D1 (de) 2003-11-20 2004-11-08 Benzofurane und benzothiophene
EP04797711A EP1685122B1 (fr) 2003-11-20 2004-11-08 Benzofuranes et benzothiophenes
JP2006540238A JP4819692B2 (ja) 2003-11-20 2004-11-08 ベンゾフラン類およびベンゾチオフェン類
KR1020067009680A KR20060101492A (ko) 2003-11-20 2004-11-08 벤조퓨란 및 벤조티오펜
US10/579,996 US7371774B2 (en) 2003-11-20 2004-11-08 Benzofurans and benzothiophenes
CNA2004800341918A CN1882562A (zh) 2003-11-20 2004-11-08 苯并呋喃和苯并噻吩类化合物
PCT/EP2004/012620 WO2005054226A1 (fr) 2003-11-20 2004-11-08 Benzofuranes et benzothiophenes
MXPA06005591A MXPA06005591A (es) 2003-11-20 2004-11-08 Benzofuranos y benzotiofenos.
CA2546651A CA2546651C (fr) 2003-11-20 2004-11-08 Benzofuranes et benzothiophenes
ARP040104274A AR046645A1 (es) 2003-11-20 2004-11-19 Benzofuranos y benzotiofenos,procedimiento de preparacion y usos
ZA200605022A ZA200605022B (en) 2003-11-20 2006-06-19 Benzofurans and benzothiophenes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0313615A FR2862646B1 (fr) 2003-11-20 2003-11-20 Nouveaux composes antidiabetiques contenant des derives benzofuranes, benzothiophenes

Publications (2)

Publication Number Publication Date
FR2862646A1 FR2862646A1 (fr) 2005-05-27
FR2862646B1 true FR2862646B1 (fr) 2006-02-24

Family

ID=34531152

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0313615A Expired - Fee Related FR2862646B1 (fr) 2003-11-20 2003-11-20 Nouveaux composes antidiabetiques contenant des derives benzofuranes, benzothiophenes

Country Status (16)

Country Link
US (1) US7371774B2 (fr)
EP (1) EP1685122B1 (fr)
JP (1) JP4819692B2 (fr)
KR (1) KR20060101492A (fr)
CN (1) CN1882562A (fr)
AR (1) AR046645A1 (fr)
AT (1) ATE400566T1 (fr)
AU (1) AU2004295036B9 (fr)
BR (1) BRPI0416790A (fr)
CA (1) CA2546651C (fr)
DE (1) DE602004014966D1 (fr)
ES (1) ES2308270T3 (fr)
FR (1) FR2862646B1 (fr)
MX (1) MXPA06005591A (fr)
WO (1) WO2005054226A1 (fr)
ZA (1) ZA200605022B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862645B1 (fr) * 2003-11-20 2007-06-22 Merck Sante Sas Composes antidiabetiques contenant des derives benzofuranes, benzothiophenes
GB0506133D0 (en) * 2005-03-24 2005-05-04 Sterix Ltd Compound
CN101830872A (zh) * 2010-04-14 2010-09-15 南方医科大学 一种3-羟基苯并呋喃类衍生物的合成方法
EA038180B1 (ru) 2015-12-09 2021-07-20 Зе Боард Оф Трастис Оф Зе Юниверсити Оф Иллинойс Бензотиофеновые селективные понижающие регуляторы эстрогеновых рецепторов
WO2018081168A2 (fr) 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Répresseurs du récepteur oestrogénique sélectifs mixtes à base de benzothiophène
AR110728A1 (es) 2017-01-06 2019-04-24 G1 Therapeutics Inc Terapia combinada para el tratamiento del cáncer
US10208011B2 (en) 2017-02-10 2019-02-19 G1 Therapeutics, Inc. Benzothiophene estrogen receptor modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1084290A (fr) * 1963-12-02 1900-01-01
SE351639B (fr) * 1964-11-11 1972-12-04 Haessle Ab
JPH10175970A (ja) * 1996-12-19 1998-06-30 Mitsui Chem Inc ベンゾチオフェン誘導体およびそれを有効成分として含有する医薬品
JP2002514636A (ja) * 1998-05-12 2002-05-21 アメリカン・ホーム・プロダクツ・コーポレイション インスリン抵抗性または高血糖症の治療に有用なフェニルオキソ−酢酸類
AU2001285067A1 (en) * 2000-09-19 2002-04-02 Warner Lambert Company Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
WO2004108709A1 (fr) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc Benzofurancarboxamides de tetrazole actifs par rapport aux p13k, utiles comme agents therapeutiques
FR2862645B1 (fr) * 2003-11-20 2007-06-22 Merck Sante Sas Composes antidiabetiques contenant des derives benzofuranes, benzothiophenes

Also Published As

Publication number Publication date
MXPA06005591A (es) 2006-08-11
ZA200605022B (en) 2007-10-31
BRPI0416790A (pt) 2007-03-06
ES2308270T3 (es) 2008-12-01
AU2004295036A1 (en) 2005-06-16
CA2546651C (fr) 2012-12-18
WO2005054226A1 (fr) 2005-06-16
FR2862646A1 (fr) 2005-05-27
AR046645A1 (es) 2005-12-14
EP1685122B1 (fr) 2008-07-09
AU2004295036B2 (en) 2010-12-23
KR20060101492A (ko) 2006-09-25
AU2004295036B9 (en) 2011-02-03
US7371774B2 (en) 2008-05-13
JP4819692B2 (ja) 2011-11-24
JP2007511556A (ja) 2007-05-10
CN1882562A (zh) 2006-12-20
EP1685122A1 (fr) 2006-08-02
US20070066680A1 (en) 2007-03-22
ATE400566T1 (de) 2008-07-15
DE602004014966D1 (de) 2008-08-21
CA2546651A1 (fr) 2005-06-16

Similar Documents

Publication Publication Date Title
FR15C0062I2 (fr) Nouveaux derives d'oxazolidinone
FR15C0037I2 (fr) Compositions monodisperses contenant du naloxol pegyle
FR13C0038I1 (fr) Nouveaux derives d'insuline
DK1569529T3 (da) Forbedringer, der angår rygeartikler
ITMI20030709A1 (it) Miscele di stabilizzanti.
DK1467629T3 (da) Granulater, der indeholder forderenzymer
NO2015005I2 (no) Flutemetamol (18F)
ATE454381T1 (de) Benzofuranderivat
HK1087105A1 (en) Benzofuran derivative
FR2838123B1 (fr) Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
MA26945A1 (fr) Derives de phenoxybenzylamine nouveaux servant d'inhibiteurs selectifs de reabsorption de serotonine.
ITTO20030660A1 (it) Struttura posteriore di motocicletta.
EP1643987A4 (fr) Derives de podophyllotoxine
ITTO20030653A1 (it) Struttura posteriore di motocicletta.
FR2862646B1 (fr) Nouveaux composes antidiabetiques contenant des derives benzofuranes, benzothiophenes
FR2862645B1 (fr) Composes antidiabetiques contenant des derives benzofuranes, benzothiophenes
NO20055002D0 (no) Benzol[1,2,5]tiadiazolforbindelser
DE50102568D1 (de) Chirale 1,3-Dioxanverbindungen
ITMI20030356V0 (it) Calzoncini per bicicletta
FR2844802B1 (fr) Nouveaux adhesifs renfermant des diacetals
ITBO20030162A1 (it) Sospensione posteriore per motocicli.
ATE370947T1 (de) 7-((1,4)dioxan-2-yl)-benzothiazol derivative als adenosin-rezeptoren liganden
EP1559719A4 (fr) Nouveaux derives de macrolides potentialisant une activite antifongique
FR2835431B1 (fr) COMPOSITION COSMETIQUE CONTENANT UNE Nx,Ng-DIACYLARGININE
DE602004018725D1 (de) Verbesserte Detektierung von Tintenstrahldruckkopfverstopfungen

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20080930